GO:0008017 | microtubule binding | 7.21% (15/208) | 4.56 | 0.0 | 0.0 |
GO:0006260 | DNA replication | 6.25% (13/208) | 5.08 | 0.0 | 0.0 |
GO:0015631 | tubulin binding | 7.21% (15/208) | 4.43 | 0.0 | 0.0 |
GO:0007018 | microtubule-based movement | 5.29% (11/208) | 5.51 | 0.0 | 0.0 |
GO:0006270 | DNA replication initiation | 3.37% (7/208) | 7.15 | 0.0 | 0.0 |
GO:0003777 | microtubule motor activity | 5.29% (11/208) | 4.82 | 0.0 | 0.0 |
GO:0008092 | cytoskeletal protein binding | 7.21% (15/208) | 3.8 | 0.0 | 0.0 |
GO:0000786 | nucleosome | 4.81% (10/208) | 5.06 | 0.0 | 0.0 |
GO:0032993 | protein-DNA complex | 4.81% (10/208) | 5.03 | 0.0 | 0.0 |
GO:0007017 | microtubule-based process | 5.77% (12/208) | 4.38 | 0.0 | 0.0 |
GO:0003774 | cytoskeletal motor activity | 5.29% (11/208) | 4.58 | 0.0 | 0.0 |
GO:0006259 | DNA metabolic process | 8.17% (17/208) | 3.3 | 0.0 | 0.0 |
GO:0042555 | MCM complex | 2.4% (5/208) | 7.4 | 0.0 | 0.0 |
GO:0046982 | protein heterodimerization activity | 4.81% (10/208) | 4.4 | 0.0 | 0.0 |
GO:0003677 | DNA binding | 13.94% (29/208) | 2.07 | 0.0 | 0.0 |
GO:0032392 | DNA geometric change | 2.4% (5/208) | 6.82 | 0.0 | 0.0 |
GO:0032508 | DNA duplex unwinding | 2.4% (5/208) | 6.82 | 0.0 | 0.0 |
GO:0005515 | protein binding | 25.0% (52/208) | 1.32 | 0.0 | 0.0 |
GO:0071103 | DNA conformation change | 2.88% (6/208) | 5.93 | 0.0 | 0.0 |
GO:0022402 | cell cycle process | 4.33% (9/208) | 4.36 | 0.0 | 0.0 |
GO:1903047 | mitotic cell cycle process | 2.88% (6/208) | 5.66 | 0.0 | 0.0 |
GO:0051276 | chromosome organization | 4.33% (9/208) | 3.95 | 0.0 | 0.0 |
GO:0033043 | regulation of organelle organization | 3.37% (7/208) | 4.54 | 0.0 | 1e-06 |
GO:0005524 | ATP binding | 16.35% (34/208) | 1.51 | 0.0 | 1e-06 |
GO:0009987 | cellular process | 32.21% (67/208) | 0.94 | 0.0 | 1e-06 |
GO:0035639 | purine ribonucleoside triphosphate binding | 16.83% (35/208) | 1.44 | 0.0 | 1e-06 |
GO:0140657 | ATP-dependent activity | 7.21% (15/208) | 2.5 | 0.0 | 2e-06 |
GO:0097159 | organic cyclic compound binding | 30.29% (63/208) | 0.94 | 0.0 | 2e-06 |
GO:0032991 | protein-containing complex | 10.58% (22/208) | 1.93 | 0.0 | 2e-06 |
GO:0090304 | nucleic acid metabolic process | 10.1% (21/208) | 1.97 | 0.0 | 2e-06 |
GO:0005488 | binding | 43.75% (91/208) | 0.68 | 0.0 | 4e-06 |
GO:0006996 | organelle organization | 5.29% (11/208) | 2.9 | 0.0 | 5e-06 |
GO:0051128 | regulation of cellular component organization | 3.37% (7/208) | 3.98 | 0.0 | 5e-06 |
GO:0006139 | nucleobase-containing compound metabolic process | 11.06% (23/208) | 1.76 | 0.0 | 6e-06 |
GO:0032559 | adenyl ribonucleotide binding | 16.83% (35/208) | 1.3 | 1e-06 | 1.1e-05 |
GO:0032555 | purine ribonucleotide binding | 17.31% (36/208) | 1.24 | 1e-06 | 1.9e-05 |
GO:0005575 | cellular_component | 18.75% (39/208) | 1.17 | 1e-06 | 2e-05 |
GO:1901265 | nucleoside phosphate binding | 18.27% (38/208) | 1.18 | 2e-06 | 2.1e-05 |
GO:0000166 | nucleotide binding | 18.27% (38/208) | 1.18 | 2e-06 | 2.1e-05 |
GO:0032553 | ribonucleotide binding | 17.31% (36/208) | 1.22 | 2e-06 | 2.1e-05 |
GO:0046483 | heterocycle metabolic process | 11.06% (23/208) | 1.63 | 2e-06 | 2.3e-05 |
GO:0097367 | carbohydrate derivative binding | 17.31% (36/208) | 1.21 | 2e-06 | 2.4e-05 |
GO:0030554 | adenyl nucleotide binding | 16.83% (35/208) | 1.23 | 2e-06 | 2.5e-05 |
GO:0006725 | cellular aromatic compound metabolic process | 11.06% (23/208) | 1.59 | 3e-06 | 3.4e-05 |
GO:0008150 | biological_process | 43.75% (91/208) | 0.6 | 3e-06 | 4e-05 |
GO:0017076 | purine nucleotide binding | 17.31% (36/208) | 1.18 | 3e-06 | 4e-05 |
GO:1901360 | organic cyclic compound metabolic process | 11.06% (23/208) | 1.56 | 4e-06 | 4.2e-05 |
GO:1901363 | heterocyclic compound binding | 18.27% (38/208) | 1.13 | 4e-06 | 4.3e-05 |
GO:2001251 | negative regulation of chromosome organization | 1.44% (3/208) | 6.44 | 4e-06 | 4.4e-05 |
GO:0036094 | small molecule binding | 18.27% (38/208) | 1.12 | 5e-06 | 4.7e-05 |
GO:0051726 | regulation of cell cycle | 2.88% (6/208) | 3.77 | 6e-06 | 5.7e-05 |
GO:0003674 | molecular_function | 57.69% (120/208) | 0.43 | 1e-05 | 9.5e-05 |
GO:0051129 | negative regulation of cellular component organization | 1.44% (3/208) | 6.08 | 1e-05 | 9.6e-05 |
GO:0010639 | negative regulation of organelle organization | 1.44% (3/208) | 6.08 | 1e-05 | 9.6e-05 |
GO:0043168 | anion binding | 17.31% (36/208) | 1.09 | 1.3e-05 | 0.000126 |
GO:0003676 | nucleic acid binding | 14.9% (31/208) | 1.2 | 1.4e-05 | 0.000131 |
GO:0010564 | regulation of cell cycle process | 2.4% (5/208) | 4.01 | 1.5e-05 | 0.000143 |
GO:0046983 | protein dimerization activity | 5.29% (11/208) | 2.3 | 1.7e-05 | 0.000157 |
GO:0033044 | regulation of chromosome organization | 1.44% (3/208) | 5.79 | 1.9e-05 | 0.000169 |
GO:0005634 | nucleus | 4.81% (10/208) | 2.39 | 2.5e-05 | 0.000217 |
GO:0016043 | cellular component organization | 6.25% (13/208) | 1.98 | 3.1e-05 | 0.000266 |
GO:0031401 | positive regulation of protein modification process | 1.44% (3/208) | 5.55 | 3.3e-05 | 0.000276 |
GO:0051347 | positive regulation of transferase activity | 1.44% (3/208) | 5.44 | 4.1e-05 | 0.000339 |
GO:0070507 | regulation of microtubule cytoskeleton organization | 1.92% (4/208) | 4.38 | 4.1e-05 | 0.000344 |
GO:0032886 | regulation of microtubule-based process | 1.92% (4/208) | 4.31 | 5e-05 | 0.000408 |
GO:0034641 | cellular nitrogen compound metabolic process | 11.06% (23/208) | 1.31 | 5.9e-05 | 0.000473 |
GO:0140097 | catalytic activity, acting on DNA | 3.37% (7/208) | 2.82 | 6.8e-05 | 0.00053 |
GO:0003887 | DNA-directed DNA polymerase activity | 1.44% (3/208) | 5.16 | 7.6e-05 | 0.00059 |
GO:0071840 | cellular component organization or biogenesis | 6.25% (13/208) | 1.83 | 8.9e-05 | 0.00068 |
GO:0034061 | DNA polymerase activity | 1.44% (3/208) | 5.08 | 9.1e-05 | 0.000686 |
GO:0051493 | regulation of cytoskeleton organization | 1.92% (4/208) | 4.08 | 9.4e-05 | 0.000698 |
GO:0009791 | post-embryonic development | 1.44% (3/208) | 5.0 | 0.000108 | 0.000789 |
GO:0051247 | positive regulation of protein metabolic process | 1.44% (3/208) | 4.93 | 0.000127 | 0.000912 |
GO:0007076 | mitotic chromosome condensation | 0.96% (2/208) | 6.66 | 0.000144 | 0.001025 |
GO:0030261 | chromosome condensation | 0.96% (2/208) | 6.34 | 0.00024 | 0.00168 |
GO:0043227 | membrane-bounded organelle | 4.81% (10/208) | 1.98 | 0.000259 | 0.001726 |
GO:0043231 | intracellular membrane-bounded organelle | 4.81% (10/208) | 1.98 | 0.000259 | 0.001726 |
GO:0043085 | positive regulation of catalytic activity | 1.44% (3/208) | 4.61 | 0.000251 | 0.001736 |
GO:0050790 | regulation of catalytic activity | 1.92% (4/208) | 3.71 | 0.000256 | 0.001749 |
GO:0032147 | activation of protein kinase activity | 0.96% (2/208) | 6.08 | 0.000358 | 0.001962 |
GO:2000816 | negative regulation of mitotic sister chromatid separation | 0.96% (2/208) | 6.08 | 0.000358 | 0.001962 |
GO:1905819 | negative regulation of chromosome separation | 0.96% (2/208) | 6.08 | 0.000358 | 0.001962 |
GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 0.96% (2/208) | 6.08 | 0.000358 | 0.001962 |
GO:0007094 | mitotic spindle assembly checkpoint signaling | 0.96% (2/208) | 6.08 | 0.000358 | 0.001962 |
GO:0071174 | mitotic spindle checkpoint signaling | 0.96% (2/208) | 6.08 | 0.000358 | 0.001962 |
GO:0071173 | spindle assembly checkpoint signaling | 0.96% (2/208) | 6.08 | 0.000358 | 0.001962 |
GO:0033048 | negative regulation of mitotic sister chromatid segregation | 0.96% (2/208) | 6.08 | 0.000358 | 0.001962 |
GO:0031577 | spindle checkpoint signaling | 0.96% (2/208) | 6.08 | 0.000358 | 0.001962 |
GO:0033046 | negative regulation of sister chromatid segregation | 0.96% (2/208) | 6.08 | 0.000358 | 0.001962 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 0.96% (2/208) | 6.08 | 0.000358 | 0.001962 |
GO:0045839 | negative regulation of mitotic nuclear division | 0.96% (2/208) | 6.08 | 0.000358 | 0.001962 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 0.96% (2/208) | 6.08 | 0.000358 | 0.001962 |
GO:0051784 | negative regulation of nuclear division | 0.96% (2/208) | 6.08 | 0.000358 | 0.001962 |
GO:0051985 | negative regulation of chromosome segregation | 0.96% (2/208) | 6.08 | 0.000358 | 0.001962 |
GO:0005819 | spindle | 0.96% (2/208) | 6.08 | 0.000358 | 0.001962 |
GO:0032502 | developmental process | 2.88% (6/208) | 2.69 | 0.000369 | 0.002003 |
GO:0065009 | regulation of molecular function | 1.92% (4/208) | 3.6 | 0.000345 | 0.002269 |
GO:0044093 | positive regulation of molecular function | 1.44% (3/208) | 4.34 | 0.000435 | 0.002333 |
GO:0009262 | deoxyribonucleotide metabolic process | 0.96% (2/208) | 5.86 | 0.0005 | 0.002552 |
GO:1905818 | regulation of chromosome separation | 0.96% (2/208) | 5.86 | 0.0005 | 0.002552 |
GO:0033047 | regulation of mitotic sister chromatid segregation | 0.96% (2/208) | 5.86 | 0.0005 | 0.002552 |
GO:0010965 | regulation of mitotic sister chromatid separation | 0.96% (2/208) | 5.86 | 0.0005 | 0.002552 |
GO:0007088 | regulation of mitotic nuclear division | 0.96% (2/208) | 5.86 | 0.0005 | 0.002552 |
GO:0099080 | supramolecular complex | 1.44% (3/208) | 4.2 | 0.000578 | 0.002895 |
GO:0016779 | nucleotidyltransferase activity | 2.4% (5/208) | 2.91 | 0.000573 | 0.002897 |
GO:0001934 | positive regulation of protein phosphorylation | 0.96% (2/208) | 5.66 | 0.000664 | 0.003235 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 0.96% (2/208) | 5.66 | 0.000664 | 0.003235 |
GO:0045860 | positive regulation of protein kinase activity | 0.96% (2/208) | 5.66 | 0.000664 | 0.003235 |
GO:0051338 | regulation of transferase activity | 1.44% (3/208) | 4.08 | 0.000748 | 0.00361 |
GO:0007093 | mitotic cell cycle checkpoint signaling | 0.96% (2/208) | 5.49 | 0.000851 | 0.003794 |
GO:0051783 | regulation of nuclear division | 0.96% (2/208) | 5.49 | 0.000851 | 0.003794 |
GO:0010562 | positive regulation of phosphorus metabolic process | 0.96% (2/208) | 5.49 | 0.000851 | 0.003794 |
GO:0042327 | positive regulation of phosphorylation | 0.96% (2/208) | 5.49 | 0.000851 | 0.003794 |
GO:0045937 | positive regulation of phosphate metabolic process | 0.96% (2/208) | 5.49 | 0.000851 | 0.003794 |
GO:0045930 | negative regulation of mitotic cell cycle | 0.96% (2/208) | 5.49 | 0.000851 | 0.003794 |
GO:0033674 | positive regulation of kinase activity | 0.96% (2/208) | 5.49 | 0.000851 | 0.003794 |
GO:0090224 | regulation of spindle organization | 1.44% (3/208) | 4.04 | 0.000811 | 0.003843 |
GO:0060236 | regulation of mitotic spindle organization | 1.44% (3/208) | 4.04 | 0.000811 | 0.003843 |
GO:0043229 | intracellular organelle | 6.25% (13/208) | 1.47 | 0.000954 | 0.00418 |
GO:0043226 | organelle | 6.25% (13/208) | 1.47 | 0.000954 | 0.00418 |
GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 0.96% (2/208) | 5.34 | 0.001061 | 0.004535 |
GO:0033045 | regulation of sister chromatid segregation | 0.96% (2/208) | 5.34 | 0.001061 | 0.004535 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 0.96% (2/208) | 5.34 | 0.001061 | 0.004535 |
GO:0051983 | regulation of chromosome segregation | 0.96% (2/208) | 5.2 | 0.001292 | 0.005481 |
GO:0043167 | ion binding | 20.19% (42/208) | 0.68 | 0.001313 | 0.005526 |
GO:0044237 | cellular metabolic process | 18.27% (38/208) | 0.72 | 0.001371 | 0.005725 |
GO:0090558 | plant epidermis development | 0.96% (2/208) | 5.08 | 0.001545 | 0.006205 |
GO:0042575 | DNA polymerase complex | 0.96% (2/208) | 5.08 | 0.001545 | 0.006205 |
GO:0051301 | cell division | 0.96% (2/208) | 5.08 | 0.001545 | 0.006205 |
GO:0010374 | stomatal complex development | 0.96% (2/208) | 5.08 | 0.001545 | 0.006205 |
GO:0031399 | regulation of protein modification process | 1.44% (3/208) | 3.73 | 0.001534 | 0.006352 |
GO:0000075 | cell cycle checkpoint signaling | 0.96% (2/208) | 4.96 | 0.001821 | 0.007093 |
GO:1901988 | negative regulation of cell cycle phase transition | 0.96% (2/208) | 4.96 | 0.001821 | 0.007093 |
GO:0010948 | negative regulation of cell cycle process | 0.96% (2/208) | 4.96 | 0.001821 | 0.007093 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 0.96% (2/208) | 4.96 | 0.001821 | 0.007093 |
GO:0043170 | macromolecule metabolic process | 18.27% (38/208) | 0.69 | 0.001995 | 0.007716 |
GO:0044238 | primary metabolic process | 22.6% (47/208) | 0.6 | 0.002012 | 0.007724 |
GO:0007346 | regulation of mitotic cell cycle | 0.96% (2/208) | 4.86 | 0.002117 | 0.008069 |
GO:0071704 | organic substance metabolic process | 23.56% (49/208) | 0.55 | 0.003054 | 0.011558 |
GO:1901987 | regulation of cell cycle phase transition | 0.96% (2/208) | 4.49 | 0.003514 | 0.013201 |
GO:0045786 | negative regulation of cell cycle | 0.96% (2/208) | 4.42 | 0.003914 | 0.014602 |
GO:1902292 | cell cycle DNA replication initiation | 0.48% (1/208) | 7.66 | 0.00493 | 0.016518 |
GO:0003688 | DNA replication origin binding | 0.48% (1/208) | 7.66 | 0.00493 | 0.016518 |
GO:1905463 | negative regulation of DNA duplex unwinding | 0.48% (1/208) | 7.66 | 0.00493 | 0.016518 |
GO:0140719 | constitutive heterochromatin formation | 0.48% (1/208) | 7.66 | 0.00493 | 0.016518 |
GO:0051095 | regulation of helicase activity | 0.48% (1/208) | 7.66 | 0.00493 | 0.016518 |
GO:0051097 | negative regulation of helicase activity | 0.48% (1/208) | 7.66 | 0.00493 | 0.016518 |
GO:1905462 | regulation of DNA duplex unwinding | 0.48% (1/208) | 7.66 | 0.00493 | 0.016518 |
GO:0043462 | regulation of ATP-dependent activity | 0.48% (1/208) | 7.66 | 0.00493 | 0.016518 |
GO:0032780 | negative regulation of ATP-dependent activity | 0.48% (1/208) | 7.66 | 0.00493 | 0.016518 |
GO:1905775 | negative regulation of DNA helicase activity | 0.48% (1/208) | 7.66 | 0.00493 | 0.016518 |
GO:2000694 | regulation of phragmoplast microtubule organization | 0.48% (1/208) | 7.66 | 0.00493 | 0.016518 |
GO:0031509 | subtelomeric heterochromatin formation | 0.48% (1/208) | 7.66 | 0.00493 | 0.016518 |
GO:0030337 | DNA polymerase processivity factor activity | 0.48% (1/208) | 7.66 | 0.00493 | 0.016518 |
GO:1902975 | mitotic DNA replication initiation | 0.48% (1/208) | 7.66 | 0.00493 | 0.016518 |
GO:1902315 | nuclear cell cycle DNA replication initiation | 0.48% (1/208) | 7.66 | 0.00493 | 0.016518 |
GO:1905774 | regulation of DNA helicase activity | 0.48% (1/208) | 7.66 | 0.00493 | 0.016518 |
GO:0006281 | DNA repair | 2.4% (5/208) | 2.13 | 0.006043 | 0.020119 |
GO:0008094 | ATP-dependent activity, acting on DNA | 1.92% (4/208) | 2.46 | 0.006194 | 0.020489 |
GO:0003678 | DNA helicase activity | 1.44% (3/208) | 2.96 | 0.00685 | 0.022518 |
GO:0006974 | DNA damage response | 2.4% (5/208) | 2.08 | 0.006949 | 0.022703 |
GO:0032501 | multicellular organismal process | 1.44% (3/208) | 2.91 | 0.0076 | 0.024676 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 2.88% (6/208) | 1.81 | 0.007869 | 0.025392 |
GO:0001932 | regulation of protein phosphorylation | 0.96% (2/208) | 3.86 | 0.008404 | 0.026792 |
GO:0045859 | regulation of protein kinase activity | 0.96% (2/208) | 3.86 | 0.008404 | 0.026792 |
GO:0099513 | polymeric cytoskeletal fiber | 0.96% (2/208) | 3.81 | 0.008998 | 0.027677 |
GO:0005874 | microtubule | 0.96% (2/208) | 3.81 | 0.008998 | 0.027677 |
GO:0043549 | regulation of kinase activity | 0.96% (2/208) | 3.81 | 0.008998 | 0.027677 |
GO:0099081 | supramolecular polymer | 0.96% (2/208) | 3.81 | 0.008998 | 0.027677 |
GO:0042325 | regulation of phosphorylation | 0.96% (2/208) | 3.81 | 0.008998 | 0.027677 |
GO:0099512 | supramolecular fiber | 0.96% (2/208) | 3.81 | 0.008998 | 0.027677 |
GO:0061731 | ribonucleoside-diphosphate reductase activity | 0.48% (1/208) | 6.66 | 0.009836 | 0.028428 |
GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor | 0.48% (1/208) | 6.66 | 0.009836 | 0.028428 |
GO:0044770 | cell cycle phase transition | 0.48% (1/208) | 6.66 | 0.009836 | 0.028428 |
GO:0000082 | G1/S transition of mitotic cell cycle | 0.48% (1/208) | 6.66 | 0.009836 | 0.028428 |
GO:0044843 | cell cycle G1/S phase transition | 0.48% (1/208) | 6.66 | 0.009836 | 0.028428 |
GO:0006269 | DNA replication, synthesis of RNA primer | 0.48% (1/208) | 6.66 | 0.009836 | 0.028428 |
GO:0044772 | mitotic cell cycle phase transition | 0.48% (1/208) | 6.66 | 0.009836 | 0.028428 |
GO:0003896 | DNA primase activity | 0.48% (1/208) | 6.66 | 0.009836 | 0.028428 |
GO:0000796 | condensin complex | 0.48% (1/208) | 6.66 | 0.009836 | 0.028428 |
GO:0016728 | oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor | 0.48% (1/208) | 6.66 | 0.009836 | 0.028428 |
GO:0005664 | nuclear origin of replication recognition complex | 0.48% (1/208) | 6.66 | 0.009836 | 0.028428 |
GO:0008152 | metabolic process | 23.56% (49/208) | 0.46 | 0.01024 | 0.029432 |
GO:0033554 | cellular response to stress | 2.4% (5/208) | 1.9 | 0.011355 | 0.032459 |
GO:0006807 | nitrogen compound metabolic process | 18.27% (38/208) | 0.53 | 0.012049 | 0.034259 |
GO:0048523 | negative regulation of cellular process | 1.92% (4/208) | 2.16 | 0.012616 | 0.035679 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 0.96% (2/208) | 3.53 | 0.012934 | 0.036381 |
GO:0051716 | cellular response to stimulus | 2.4% (5/208) | 1.85 | 0.013107 | 0.036672 |
GO:0051246 | regulation of protein metabolic process | 1.44% (3/208) | 2.58 | 0.014188 | 0.039485 |
GO:0008622 | epsilon DNA polymerase complex | 0.48% (1/208) | 6.08 | 0.014718 | 0.040113 |
GO:0000278 | mitotic cell cycle | 0.48% (1/208) | 6.08 | 0.014718 | 0.040113 |
GO:0090627 | plant epidermal cell differentiation | 0.48% (1/208) | 6.08 | 0.014718 | 0.040113 |
GO:0010052 | guard cell differentiation | 0.48% (1/208) | 6.08 | 0.014718 | 0.040113 |
GO:0048519 | negative regulation of biological process | 1.92% (4/208) | 2.09 | 0.014832 | 0.040215 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 1.44% (3/208) | 2.52 | 0.015715 | 0.042175 |
GO:0010604 | positive regulation of macromolecule metabolic process | 1.44% (3/208) | 2.52 | 0.015715 | 0.042175 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 3.85% (8/208) | 1.32 | 0.015891 | 0.042217 |
GO:0032774 | RNA biosynthetic process | 1.92% (4/208) | 2.06 | 0.015891 | 0.04243 |
GO:0009893 | positive regulation of metabolic process | 1.44% (3/208) | 2.51 | 0.016111 | 0.042585 |
GO:0009888 | tissue development | 0.96% (2/208) | 3.31 | 0.017484 | 0.045528 |
GO:0019220 | regulation of phosphate metabolic process | 0.96% (2/208) | 3.31 | 0.017484 | 0.045528 |
GO:0051174 | regulation of phosphorus metabolic process | 0.96% (2/208) | 3.31 | 0.017484 | 0.045528 |
GO:0110165 | cellular anatomical entity | 10.1% (21/208) | 0.71 | 0.018078 | 0.046843 |
GO:0008047 | enzyme activator activity | 0.96% (2/208) | 3.27 | 0.0183 | 0.047184 |
GO:0000776 | kinetochore | 0.48% (1/208) | 5.66 | 0.019576 | 0.049268 |
GO:0043138 | 3'-5' DNA helicase activity | 0.48% (1/208) | 5.66 | 0.019576 | 0.049268 |
GO:0048608 | reproductive structure development | 0.48% (1/208) | 5.66 | 0.019576 | 0.049268 |
GO:0009908 | flower development | 0.48% (1/208) | 5.66 | 0.019576 | 0.049268 |
GO:0090567 | reproductive shoot system development | 0.48% (1/208) | 5.66 | 0.019576 | 0.049268 |